← brief for 2026-09-28 · Slowing decline

Prospective 96-week study to evaluate efficacy and safety of tacrolimus and glucocorticoid against mycophenolate and glucocorticoid as continuous induction-maintenance treatment for Class III/IV without or with Class V lupus nephritis

Paper No results yet Not peer reviewed

Key takeaways

This is a large trial in Asia testing a specific drug mix for lupus kidney disease. It compares two standard treatments over 96 weeks. The record describes the study plan, but it does not include the final results yet.

Source

Paper · Kidney International · 2026-09-28
https://www.kidney-international.org/article/S0085-2538(26)00817-3/fulltext?rss=yes